Louise Flintoft, Theranostics Product Manager, Leica Biosystems, Newcastle, is a Graduate of Physiology from the University of Newcastle upon Tyne. She is responsible for the global roll-out and day to day management of the Bond™ Oracle™ HER2 IHC System. Louise Flintoft joined the Novocastra Laboratories in 2001 as an R&D research associate, generating antibodies for IHC from hybridomas in cell culture, before seconding to the USA sales organization as an antibody specialist responsible for training sales and support staff. On her return to Newcastle she product managed the reagents for Leica BOND instruments.
Article01. Oct 2008 Authors: E Hyjek, Louise Flintoft, Nigel Piggott, Ph.D. , Mark Rees, Ph.D. , Elizabeth Udale, Victoria Reid, Ph.D. , Jeanette Doherty, Paul Scorer, Gary McIntosh, Ph.D. , A Chadburn, D M Knowles, I I Bansal Institutes: Leica Biosystems, Wetzlar, Germany, Weill Cornell Medical College, Department of Pathology & Laboratory Medicine, New York, NY, USACD33 Antigen Detection by PWS44 a New Monoclonal Antibody Reactive in Paraffin Tissues Sections: Pattern of Reactivity and Potential Diagnostic Utility.